Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis

Atopic Dermatitis

Sensitisation to outdoor and indoor fungi in atopic dermatitis patients and the relation to the occurrence of food allergy to peanuts and walnuts

Mycoses.

Čelakovská J, Bukač J, Ettler K, Vaneckova J, Ettlerova K, Krejsek J

doi: 10.1111/myc.12795.

Allergic Diseases

Understanding Food Related Allergic Reactions through a US National Patient Registry

J Allergy Clin Immunol Pract.

Fierstein JL, Brown D, Gupta R, Bilaver L

doi: 10.1016/j.jaip.2020.08.011.

COMMENTED

Melanoma and Skin Cancer

The Potential of Behavioral Counseling to Prevent Skin Cancer

JAMA Dermatol.

Buller DB, Heckman CJ, Manne SL.

doi: 10.1001/

Atopic Dermatitis

Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials

Dermatol Ther (Heidelb).

Simpson EL

doi: 10.1007/s13555-017-0181-6.

Atopic Dermatitis

Influence of topical steroids on intraocular pressure in patients with atopic dermatitis

Allergol Int.

Tamagawa-Mineoka R, Yasuoka N, Ueta M, Katoh N

doi: 10.1016/j.alit.2018.01.004.

Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials

J Am Acad Dermatol.

Fleming P, Drucker AM

doi: 10.1016/j.jaad.2017.09.052.

Atopic Dermatitis

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life, and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomised trial

J Eur Acad Dermatol Venereol

Wollenberg A, Nakahara T, Maari C, Peris K, Lio P, Augustin M, Silverberg JI, Rueda MJ, DeLozier AM, Pierce E, Yang FE, Sun L, Ball S, Tauber M, Paul C

doi: 10.1111/jdv.17278

Atopic Dermatitis

Nemolizumab plus topical agents in patients with atopic dermatitis and moderate-to-severe pruritus provide improvement in pruritus and signs of atopic dermatitis for up to 68 weeks: results from two phase III, long-term studies

Br J Dermatol

Kabashima K, Matsumura T, Komazaki H, Kawashima M, Nemolizumab JP01, JP02 Study Group.

doi: 10.1111/bjd.20873

Atopic Dermatitis

Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000-2015: a retrospective multicentre study

J Eur Acad Dermatol Venereol.

Dickel H, Kuhlmann L, Bauer A, Bircher AJ, Breuer K, Fuchs T, Grabbe J, Mahler V, Pföhler C, Przybilla B, Rieker-Schwienbacher J, Schröder-Kraft C, Simon D, Treudler R, Weisshaar E, Worm M, Trinder E, Geier J

doi: 10.1111/jdv.16250.

Related content

Sensitisation to outdoor and indoor fungi in atopic dermatitis patients and the relation to the occurrence of food allergy to peanuts and walnuts

Understanding Food Related Allergic Reactions through a US National Patient Registry

The Potential of Behavioral Counseling to Prevent Skin Cancer

Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials

Influence of topical steroids on intraocular pressure in patients with atopic dermatitis

Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life, and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomised trial

Nemolizumab plus topical agents in patients with atopic dermatitis and moderate-to-severe pruritus provide improvement in pruritus and signs of atopic dermatitis for up to 68 weeks: results from two phase III, long-term studies

Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000-2015: a retrospective multicentre study